Avanos Medical (AVNS) Invested Capital (2013 - 2026)

Avanos Medical has disclosed Invested Capital across 14 years of filings, most recently posting $869.4 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $869.4 million, down 7.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $869.4 million (down 7.25% YoY), and the FY2025 annual result was $868.5 million, up 3202.28% from the prior year.
• Invested Capital came in at $869.4 million for Q1 2026 at Avanos Medical, roughly flat from $868.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.9 billion in Q1 2022 to a low of -$149.1 million in Q2 2024.
• The 5-year median for Invested Capital is $871.4 million (2025), against an average of $865.1 million.
• Across the five-year window, Invested Capital sank 212.27% in 2024 and jumped 3202.28% in 2025, its largest moves.
• Avanos Medical's Invested Capital stood at $1.5 billion in 2022, then dropped by 8.03% to $1.4 billion in 2023, then tumbled by 98.12% to $26.3 million in 2024, then surged by 3202.28% to $868.5 million in 2025, then grew by 0.1% to $869.4 million in 2026.
• The last three Invested Capital figures came in at $869.4 million (Q1 2026), $868.5 million (Q4 2025), and $871.4 million (Q3 2025), per Business Quant data.